Applied Finance Capital Management’s ResMed RMD Stock Holding History

Applied Finance Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263K	Sell	1,352 -324	-19%	-$67.2K	0.02%	195
2026 Q1	$376K	Buy	1,676 +403	+32%	+$100K	0.03%	169
2025 Q4	$307K	Buy	+1,273	New	+$326K	0.02%	194
2025 Q2	–	Sell	-3,588	Closed	-$803K	–	360
2025 Q1	$803K	Buy	3,588 +632	+21%	+$148K	0.06%	144
2024 Q4	$676K	Buy	+2,956	New	+$712K	0.03%	151
2024 Q3	–	Sell	-3,175	Closed	-$608K	–	322
2024 Q2	$608K	Buy	+3,175	New	+$644K	0.03%	165

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Applied Finance Capital Management's RMD Position: Q2 2026 in Review

Applied Finance Capital Management reduced its ResMed (RMD) stake by 19% in Q2 2026, selling an estimated $67.2K and leaving 1,352 shares worth $263K. The position accounts for 0.02% of the portfolio, ranked #195.

Applied Finance Capital Management first reported a position in RMD in Q2 2024 and has held it in 6 quarters since. The position peaked at $803K in Q1 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Applied Finance Capital Management held 1,352 shares of ResMed worth $263K as of Q2 2026.
Applied Finance Capital Management sold 324 ResMed shares in Q2 2026, an estimated $67.2K.
ResMed made up 0.02% of Applied Finance Capital Management's portfolio in Q2 2026, its #195 holding.
Applied Finance Capital Management first reported a position in ResMed in Q2 2024 and has held it in 6 quarters since.
Applied Finance Capital Management's ResMed position peaked at $803K in Q1 2025.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.